Bosentan Aids Treprostinil in Pulmonary Artery Hypertension
This is a medscape article please log in to the message board under the PH forum for details.
NEW YORK (Reuters Health) Aug 12 - In certain patients with moderate-to-severe pulmonary artery hypertension (PAH), the addition of oral bosentan to subcutaneous treprostinil-based therapy can produce further clinical improvement, investigators report in the July issue of Chest.